Needle Free Diabetes Care Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Around 422 million people across the globe suffer from diabetes. Diabetic patients have to check their blood sugar level several times a day, by pricking their finger with a lancet. This is very painful and uncomfortable for the patients, which results in less frequent testing and thereby affects the control of blood sugar levels. Therefore, many companies are developing needle-free alternatives that eliminates the painful procedure.
MARKET DYNAMICS
Needle free diabetes care market is anticipated to grow in the forecast period owing to rise in the geriatric population, increasing prevalence of diabetic population, high incidence of obesity, and change in food habits. Moreover, technological advancements for diabetes care by market players is likely to create opportunity during the forecast period.
MARKET SCOPE
The "Global Needle Free Diabetes Care Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of needle free diabetes care market with detailed market segmentation by device type, end user and geography. The global needle free diabetes care market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading needle free diabetes care market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global needle free diabetes care market is segmented on the basis of device type and end user. Based on device type, the market is segmented as treatment devices, and diagnostics devices. Based on end user, the market is segmented as diagnostic centers, hospitals and clinics, and consumer.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global needle free diabetes care market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The needle free diabetes care market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting needle free diabetes care market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the needle free diabetes care market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global needle free diabetes care market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The needle free diabetes care market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting needle free diabetes care market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the needle free diabetes care market in these regions.
MARKET PLAYERS
The report covers key developments in the needle free diabetes care market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from needle free diabetes care market are anticipated to lucrative growth opportunities in the future with the rising demand for needle free diabetes care in the global market. Below mentioned is the list of few companies engaged in the needle free diabetes care market.
The report also includes the profiles of key needle free diabetes care market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Zogenix, Inc.
- 3M
- Antares Pharma Inc.
- Glide Pharmaceutical Technologies Ltd.
- Injex Pharma AG
- Pharmajet, Inc.
- Bioject Medical Technologies, Inc.
- Medtronic, Inc.
- Johnson and Johnson, Inc.
- Pancreum LLC
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Needle Free Diabetes Care Market - By Device Type
1.3.2 Needle Free Diabetes Care Market - By End User
1.3.3 Needle Free Diabetes Care Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEEDLE FREE DIABETES CARE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEEDLE FREE DIABETES CARE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NEEDLE FREE DIABETES CARE MARKET - GLOBAL MARKET ANALYSIS
6.1. NEEDLE FREE DIABETES CARE - GLOBAL MARKET OVERVIEW
6.2. NEEDLE FREE DIABETES CARE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NEEDLE FREE DIABETES CARE MARKET - REVENUE AND FORECASTS TO 2028 - DEVICE TYPE
7.1. OVERVIEW
7.2. DEVICE TYPE MARKET FORECASTS AND ANALYSIS
7.3. TREATMENT DEVICES
7.3.1. Overview
7.3.2. Treatment Devices Market Forecast and Analysis
7.3.3. Insulin patches Market
7.3.3.1. Overview
7.3.3.2. Insulin patches Market Forecast and Analysis
7.3.4. Jet Injectors Market
7.3.4.1. Overview
7.3.4.2. Jet Injectors Market Forecast and Analysis
7.3.5. Insulin pens Market
7.3.5.1. Overview
7.3.5.2. Insulin pens Market Forecast and Analysis
7.3.6. Insulin pumps Market
7.3.6.1. Overview
7.3.6.2. Insulin pumps Market Forecast and Analysis
7.3.7. Insulin infuser Market
7.3.7.1. Overview
7.3.7.2. Insulin infuser Market Forecast and Analysis
7.4. DIAGNOSTICS DEVICES
7.4.1. Overview
7.4.2. Diagnostics Devices Market Forecast and Analysis
7.4.3. Continuous glucose monitoring Market
7.4.3.1. Overview
7.4.3.2. Continuous glucose monitoring Market Forecast and Analysis
7.4.4. Instant glucose monitoring Market
7.4.4.1. Overview
7.4.4.2. Instant glucose monitoring Market Forecast and Analysis
8. NEEDLE FREE DIABETES CARE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSTIC CENTERS
8.3.1. Overview
8.3.2. Diagnostic Centers Market Forecast and Analysis
8.4. HOSPITALS AND CLINICS
8.4.1. Overview
8.4.2. Hospitals and Clinics Market Forecast and Analysis
8.5. CONSUMER
8.5.1. Overview
8.5.2. Consumer Market Forecast and Analysis
9. NEEDLE FREE DIABETES CARE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Needle Free Diabetes Care Market Overview
9.1.2 North America Needle Free Diabetes Care Market Forecasts and Analysis
9.1.3 North America Needle Free Diabetes Care Market Forecasts and Analysis - By Device Type
9.1.4 North America Needle Free Diabetes Care Market Forecasts and Analysis - By End User
9.1.5 North America Needle Free Diabetes Care Market Forecasts and Analysis - By Countries
9.1.5.1 United States Needle Free Diabetes Care Market
9.1.5.1.1 United States Needle Free Diabetes Care Market by Device Type
9.1.5.1.2 United States Needle Free Diabetes Care Market by End User
9.1.5.2 Canada Needle Free Diabetes Care Market
9.1.5.2.1 Canada Needle Free Diabetes Care Market by Device Type
9.1.5.2.2 Canada Needle Free Diabetes Care Market by End User
9.1.5.3 Mexico Needle Free Diabetes Care Market
9.1.5.3.1 Mexico Needle Free Diabetes Care Market by Device Type
9.1.5.3.2 Mexico Needle Free Diabetes Care Market by End User
9.2. EUROPE
9.2.1 Europe Needle Free Diabetes Care Market Overview
9.2.2 Europe Needle Free Diabetes Care Market Forecasts and Analysis
9.2.3 Europe Needle Free Diabetes Care Market Forecasts and Analysis - By Device Type
9.2.4 Europe Needle Free Diabetes Care Market Forecasts and Analysis - By End User
9.2.5 Europe Needle Free Diabetes Care Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Needle Free Diabetes Care Market
9.2.5.1.1 Germany Needle Free Diabetes Care Market by Device Type
9.2.5.1.2 Germany Needle Free Diabetes Care Market by End User
9.2.5.2 France Needle Free Diabetes Care Market
9.2.5.2.1 France Needle Free Diabetes Care Market by Device Type
9.2.5.2.2 France Needle Free Diabetes Care Market by End User
9.2.5.3 Italy Needle Free Diabetes Care Market
9.2.5.3.1 Italy Needle Free Diabetes Care Market by Device Type
9.2.5.3.2 Italy Needle Free Diabetes Care Market by End User
9.2.5.4 Spain Needle Free Diabetes Care Market
9.2.5.4.1 Spain Needle Free Diabetes Care Market by Device Type
9.2.5.4.2 Spain Needle Free Diabetes Care Market by End User
9.2.5.5 United Kingdom Needle Free Diabetes Care Market
9.2.5.5.1 United Kingdom Needle Free Diabetes Care Market by Device Type
9.2.5.5.2 United Kingdom Needle Free Diabetes Care Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Needle Free Diabetes Care Market Overview
9.3.2 Asia-Pacific Needle Free Diabetes Care Market Forecasts and Analysis
9.3.3 Asia-Pacific Needle Free Diabetes Care Market Forecasts and Analysis - By Device Type
9.3.4 Asia-Pacific Needle Free Diabetes Care Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Needle Free Diabetes Care Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Needle Free Diabetes Care Market
9.3.5.1.1 Australia Needle Free Diabetes Care Market by Device Type
9.3.5.1.2 Australia Needle Free Diabetes Care Market by End User
9.3.5.2 China Needle Free Diabetes Care Market
9.3.5.2.1 China Needle Free Diabetes Care Market by Device Type
9.3.5.2.2 China Needle Free Diabetes Care Market by End User
9.3.5.3 India Needle Free Diabetes Care Market
9.3.5.3.1 India Needle Free Diabetes Care Market by Device Type
9.3.5.3.2 India Needle Free Diabetes Care Market by End User
9.3.5.4 Japan Needle Free Diabetes Care Market
9.3.5.4.1 Japan Needle Free Diabetes Care Market by Device Type
9.3.5.4.2 Japan Needle Free Diabetes Care Market by End User
9.3.5.5 South Korea Needle Free Diabetes Care Market
9.3.5.5.1 South Korea Needle Free Diabetes Care Market by Device Type
9.3.5.5.2 South Korea Needle Free Diabetes Care Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Needle Free Diabetes Care Market Overview
9.4.2 Middle East and Africa Needle Free Diabetes Care Market Forecasts and Analysis
9.4.3 Middle East and Africa Needle Free Diabetes Care Market Forecasts and Analysis - By Device Type
9.4.4 Middle East and Africa Needle Free Diabetes Care Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Needle Free Diabetes Care Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Needle Free Diabetes Care Market
9.4.5.1.1 South Africa Needle Free Diabetes Care Market by Device Type
9.4.5.1.2 South Africa Needle Free Diabetes Care Market by End User
9.4.5.2 Saudi Arabia Needle Free Diabetes Care Market
9.4.5.2.1 Saudi Arabia Needle Free Diabetes Care Market by Device Type
9.4.5.2.2 Saudi Arabia Needle Free Diabetes Care Market by End User
9.4.5.3 U.A.E Needle Free Diabetes Care Market
9.4.5.3.1 U.A.E Needle Free Diabetes Care Market by Device Type
9.4.5.3.2 U.A.E Needle Free Diabetes Care Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Needle Free Diabetes Care Market Overview
9.5.2 South and Central America Needle Free Diabetes Care Market Forecasts and Analysis
9.5.3 South and Central America Needle Free Diabetes Care Market Forecasts and Analysis - By Device Type
9.5.4 South and Central America Needle Free Diabetes Care Market Forecasts and Analysis - By End User
9.5.5 South and Central America Needle Free Diabetes Care Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Needle Free Diabetes Care Market
9.5.5.1.1 Brazil Needle Free Diabetes Care Market by Device Type
9.5.5.1.2 Brazil Needle Free Diabetes Care Market by End User
9.5.5.2 Argentina Needle Free Diabetes Care Market
9.5.5.2.1 Argentina Needle Free Diabetes Care Market by Device Type
9.5.5.2.2 Argentina Needle Free Diabetes Care Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NEEDLE FREE DIABETES CARE MARKET, KEY COMPANY PROFILES
11.1. ZOGENIX, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. 3M
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ANTARES PHARMA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLIDE PHARMACEUTICAL TECHNOLOGIES LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. INJEX PHARMA AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PHARMAJET, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BIOJECT MEDICAL TECHNOLOGIES, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MEDTRONIC, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. JOHNSON AND JOHNSON, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PANCREUM LLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Zogenix, Inc.
2. 3M
3. Antares Pharma Inc.
4. Glide Pharmaceutical Technologies Ltd.
5. Injex Pharma AG
6. Pharmajet, Inc.
7. Bioject Medical Technologies, Inc.
8. Medtronic, Inc.
9. Johnson and Johnson, Inc.
10. Pancreum LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For